文献速递心脑血管急症重症综合管理与镇静镇痛

体外生命支持患者的NSE血清水平——与神经功能预后相关吗

NSE serum levels in extracorporeal life support patients-Relevance for neurological outcome?
PubMed 文献 · Resuscitation · 2017-09-12
一句话结论心脏骤停后接受体外生命支持的患者中,NSE峰值升高提示严重弥漫性缺氧性脑损伤,NSE>100μg/L者院内死亡率71.7%。

该研究纳入159例心肺复苏后患者,检测NSE 48小时峰值及变化趋势,评估其预测脑损伤、院内死亡和长期预后的价值。队列总死亡率为53.5%,相关脑损伤发生率为34.6%,其中严重弥漫性缺氧性损伤占23.2%。NSE峰值在有和无局灶性缺血的患者间相当,但在严重弥漫性缺氧性损伤患者中升高(p<0.0001)。NSE峰值预测脑损伤和院内死亡的ROC曲线下面积分别为0.73(95%CI 0.65-0.82)和0.74(95%CI 0.66-0.81)。NSE>100μg/L者院内死亡率为71.7%,NSE<100μg/L者为36.4%、良好神经功能状态占67.9%。

要点

  • 心肺复苏后接受体外生命支持的患者中,NSE峰值在严重弥漫性缺氧性损伤患者中升高(p<0.0001),而在有和无局灶性缺血的患者间相当。
  • NSE峰值预测脑损伤的ROC曲线下面积为0.73(95%CI 0.65-0.82),预测院内死亡的ROC曲线下面积为0.74(95%CI 0.66-0.81)。
  • NSE>100μg/L预测脑损伤的敏感度为0.6(95%CI 0.49-0.72)、特异度为0.74(95%CI 0.63-0.84);NSE升高预测脑损伤的敏感度为0.82(95%CI 0.69-0.92)、特异度为0.43(95%CI 0.31-0.55)。
  • NSE>100μg/L者院内死亡率为71.7%,NSE<100μg/L者为36.4%;出院患者中46.2%神经功能良好(CPC 1-2),NSE<100μg/L者良好神经功能状态占67.9%。

适用人群与场景

  • 心肺复苏后接受体外生命支持的患者,共159例。

研究设计与关键结果

  • 研究类型为队列研究,纳入159例心肺复苏后患者,检测NSE 48小时峰值水平及变化趋势。
  • 队列总死亡率为53.5%,相关脑损伤发生率为34.6%,严重弥漫性缺氧性损伤发生率为23.2%。
  • NSE峰值在有和无局灶性缺血的患者间相当,但在严重弥漫性缺氧性损伤患者中升高(p<0.0001)。
  • NSE峰值预测脑损伤的ROC曲线下面积为0.73(95%CI 0.65-0.82),预测院内死亡的ROC曲线下面积为0.74(95%CI 0.66-0.81)。
  • NSE升高见于56.6%的患者,其预测脑损伤的敏感度为0.82(95%CI 0.69-0.92)、特异度为0.43(95%CI 0.31-0.55)。
  • NSE峰值>100μg/L预测脑损伤的敏感度为0.6(95%CI 0.49-0.72)、特异度为0.74(95%CI 0.63-0.84)。
  • NSE>100μg/L者院内死亡率为71.7%;NSE<100μg/L者院内死亡率为36.4%。
  • 出院患者中46.2%神经功能良好(CPC 1-2);NSE<100μg/L者中良好神经功能状态占67.9%。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,NSE监测可可靠地提示心肺复苏后接受体外生命支持患者的有关脑损伤。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Good neurological outcome is a major determinant after cardiac resuscitation. Extracorporeal life support may rapidly stabilize the patient, but cerebral ischemia remains a frequent complication relevant for further therapy. The aim of this study was to prove the value of NSE to indicate cerebral injury in patients with extracorporeal support after CPR.

METHODS: 159 patients with CPR were included. NSE 48h peak levels and trends were tested for usability as predictive marker of brain injury, in-hospital mortality and long-term outcome.

RESULTS: Overall mortality in this cohort was 53.5%. Incidence of relevant brain injury was 34.6% with severe diffuse hypoxia in 23.2%. NSE peaks were comparable in patients with and without focal ischemia, but were increased in patients with severe diffuse hypoxic injury (p<0.0001). ROC analysis (area under the curve) of peak values indicating brain injury and in-hospital mortality was 0.73 (95% confidence interval [CI] 0.65-0.82) and 0.74 (95% CI 0.66-0.81), respectively. NSE increased in 56.6% of patients with a sensitivity of 0.82 (95% CI 0.69-0.92) and a specificity of 0.43 (CI 0.0.31-0.55) indicating cerebral injury. Sensitivity and specificity of NSE peak levels >100μg/L was 0.6 (CI 0.49-0.72) and 0.74 (CI 0.63-0.84). In-hospital mortality of patients with NSE >100μg/L was 71.7%. 46.2% of discharged patients are in good neurological status (cerebral performance category scale [CPC] 1-2). Patients with NSE <100μg/L showed an in-hospital mortality of 36.4%, and good neurological status in 67.9%.

CONCLUSION: NSE monitoring reliably indicates relevant cerebral injury in patients on extracorporeal support after cardiopulmonary resuscitation.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Floerchinger B, Philipp A, Camboni D, et al. NSE serum levels in extracorporeal life support patients-Relevance for neurological outcome? Resuscitation. 2017. PMID: 28916477. doi:10.1016/j.resuscitation.2017.09.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。